SALT LAKE CITY, Utah, Sept. 29, 2016 -- Park City Group’s subsidiary, ReposiTrak, Inc., the leading provider of Compliance Management and Track & Trace solutions for food, pharma and dietary supplement safety, announces today that Randy Fields, Chairman and CEO of Park City Group, will participate in The Wall Street Journal (WSJ) Global Food Forum on October 6th in New York City. Fields joins other industry, academia and regulatory executives who will each be interviewed by WSJ editors in front of an audience to explore key challenges and opportunities in the business of food. During his session, titled “Safe Sourcing,” Fields will address the Food Safety Modernization Act’s ability to make food safer, how the opacity of the global food supply chain enables both food fraud and food crime and the expansion of superbugs.
|
|||
The WSJ is launching the first annual Global Food Forum in response to food's growing impact on the world's economy and to further explore the opportunities and challenges facing the United States. The Global Food Forum is one of the WSJ Executive Conferences that convenes decision makers, innovators and thought leaders from the public and private sector to spark new ideas and impact change.
“I am honored to have been invited to participate as a speaker in the first annual Global Food Forum,” said Randy Fields. “I look forward to sharing the insights we have learned in our conversations with many retailer and wholesaler senior executives, many of whom are now ReposiTrak customers.”
About ReposiTrak
ReposiTrak® provides food retailers and suppliers with a robust solution to help them protect their brands and remain in compliance with the rapidly evolving regulations in the Food Safety Modernization Act. Additionally, ReposiTrak enables traceability as products and their ingredients move between trading partners. ReposiTrak is a wholly-owned subsidiary of Park City Group (NASDAQ:PCYG) and was co-founded with Leavitt Partners. More information is available at www.repositrak.com.
About Park City Group
Park City Group (PCYG) is a Software-as-a-Service (“SaaS”) provider that brings unique visibility to the consumer goods supply chain, delivering actionable information to ensure products are available when and where consumers demand them, helping retailers and suppliers to ‘Sell More, Stock Less, and See Everything’. Park City Group’s technology also assists all participants in the food and drug supply chains to comply with food and drug safety regulations through the Company’s ReposiTrak subsidiary. More information is available at www.parkcitygroup.com.
Media Contact Ronald Margulis RAM Communications +1 908.272.3930 [email protected]


ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
OpenAI Explores Massive Funding Round at $750 Billion Valuation
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 



